Mood swings in perimenopause
One week you feel fine. The next you're crying at something small, snapping at people you love, or feeling a heaviness you can't explain. If your mood has become unpredictable in a way that doesn't feel like you, there is a very good reason — and it is not a mental health crisis. It is a hormonal one.
Here's what's actually happening
The mood changes of perimenopause are not caused by low estrogen — they are caused by unstable estrogen. This is an important distinction. Research shows that it is the wild swings in estrogen levels, up and down unpredictably, that drive mood disruption during the transition. In one study of perimenopausal women with depressive symptoms, 90% had fluctuating estradiol levels, and the greater the fluctuation, the worse the mood symptoms. Your brain is not reacting to less estrogen — it is reacting to the instability of constantly changing levels.
Progesterone matters here too. When progesterone is absent or very low — which happens more frequently as ovulation becomes irregular in perimenopause — mood symptoms are significantly worse. Progesterone has a calming influence on the brain, and its decline removes a buffer your nervous system has relied on for decades.
Together, these hormonal shifts affect the brain's mood-regulating systems in real, measurable ways — including the systems that regulate serotonin and dopamine, and the brain's stress response. This is not emotional sensitivity or difficulty coping. This is your brain chemistry changing in response to hormonal signals it has always depended on.
Some women are more sensitive to these fluctuations than others. There is no way to predict in advance who will be most affected. But if your mood has become significantly harder to manage during this transition, that is meaningful clinical information — not a character flaw.
In perimenopause vs. menopause
Mood symptoms tend to be most intense during perimenopause, when hormonal swings are at their most erratic. This is when the brain is most reactive to the instability. Large studies show that the risk of developing significant depressive symptoms during perimenopause is two to four times higher than before the transition — even in women who have never struggled with depression before.
For most women, mood symptoms improve after menopause, once hormone levels settle into a lower but more stable state. The instability is the driver — and when it resolves, the mood often follows. Women who have a longer perimenopause tend to have a harder time with mood, precisely because the instability lasts longer.
Hormone therapy has strong evidence for mood symptoms during perimenopause — and it works through a different mechanism than antidepressants. Rather than targeting neurotransmitters directly, it works by stabilizing the hormonal fluctuations that are causing the disruption in the first place. A landmark clinical trial found that transdermal estradiol combined with micronized progesterone cut the rate of clinically significant depressive symptoms nearly in half over 12 months — and that benefit held even after accounting for any relief of hot flashes. The mood benefit was independent. Timing matters: the evidence is strongest when treatment begins in early perimenopause. A large study of 920 women found hormone therapy reduced mood-related symptoms by nearly 45% within about three and a half months.
The sources behind this page
- Brown L, Hunter MS, Chen R, et al. Promoting good mental health over the menopause transition. Lancet. 2024.
- Joffe H, de Wit A, Coborn J, et al. Impact of estradiol variability and progesterone on mood in perimenopausal women with depressive symptoms. The Journal of Clinical Endocrinology and Metabolism. 2020.
- Fidecicchi T, Giannini A, Chedraui P, et al. Neuroendocrine mechanisms of mood disorders during menopause transition: a narrative review and future perspectives. Maturitas. 2024.
- Gordon JL, Sander B. The role of estradiol fluctuation in the pathophysiology of perimenopausal depression: a hypothesis paper. Psychoneuroendocrinology. 2021.
- Gordon JL, Rubinow DR, Eisenlohr-Moul TA, et al. Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial. JAMA Psychiatry. 2018.
- Glynne S, Kamal A, McColl L, et al. Transdermal oestradiol and testosterone therapy for menopausal depression and mood symptoms: retrospective cohort study. The British Journal of Psychiatry. 2025.